Alternative pre-mRNA splicing as a mechanism for terminating Toll-like Receptor signaling

Frank Fang Yao Lee1,2, Scott Alper1,2

  • 1Department of Immunology and Genomic Medicine and Center for Genes, Environment, and Health, National Jewish Health, Denver, CO, United States.

Frontiers in Immunology
|December 19, 2022
PubMed

Insights

Alternative splicing of Toll-like receptor (TLR) pathway genes produces inhibitory proteins. This negative feedback mechanism limits persistent inflammation and may play a role in inflammatory diseases.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Toll-like receptor (TLR) signaling is crucial for combating infections but persistent activation causes tissue damage and inflammatory diseases.
  • Effective termination of TLR signaling is essential to prevent detrimental inflammation.
  • Alternative pre-mRNA splicing is a key mechanism regulating gene expression and protein function.

Purpose of the Study:

  • To review the role of alternative splicing in generating negative regulators of TLR signaling.
  • To explore the function, production, and disease implications of these inhibitory isoforms.
  • To highlight the need for a systemic analysis of alternative splicing in the TLR pathway.

Main Methods:

  • Literature review of studies on alternative splicing in the TLR signaling pathway.
  • Analysis of known alternative mRNA isoforms and their protein products.
  • Examination of the regulatory mechanisms controlling alternative splicing in response to immune challenges.

Main Results:

  • Many TLR signaling genes produce alternative mRNA isoforms encoding dominant-negative inhibitors.
  • These inhibitory isoforms are often induced by immune challenge, forming a negative feedback loop.
  • Alternative splicing provides a mechanism to limit and terminate TLR signaling.

Conclusions:

  • Alternative splicing is a critical, yet understudied, mechanism for controlling TLR-mediated inflammation.
  • Dysregulation of these inhibitory isoforms may contribute to inflammatory disorders.
  • Further systemic investigation is needed to fully understand this regulatory network and its therapeutic potential.

Related Concept Videos

Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.6K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.6K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.7K
Termination of Translation01:44

Termination of Translation

The large ribosomal subunit has several important structures essential to translation. These include the peptidyl transferase center (PTC) - which is the site where the peptide bond is formed - and a large, internal, water-filled tube through which the nascent polypeptide moves. This latter structure is called the Peptide Exit Tunnel, and it begins at the PTC and spans the body of the large ribosomal subunit. During translation, as the nascent polypeptide chain is synthesized, it passes through...
25.6K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
15.8K